13.76
+0.01(+0.07%)
Currency In USD
| Previous Close | 13.75 |
| Open | 13.73 |
| Day High | 13.98 |
| Day Low | 13.51 |
| 52-Week High | 17.75 |
| 52-Week Low | 7.86 |
| Volume | 1.03M |
| Average Volume | 2.12M |
| Market Cap | 1.64B |
| PE | -13.23 |
| EPS | -1.04 |
| Moving Average 50 Days | 14.01 |
| Moving Average 200 Days | 12.81 |
| Change | 0.01 |
If you invested $1000 in Arcutis Biotherapeutics, Inc. (ARQT) since IPO date, it would be worth $631.19 as of July 03, 2025 at a share price of $13.76. Whereas If you bought $1000 worth of Arcutis Biotherapeutics, Inc. (ARQT) shares 3 years ago, it would be worth $626.45 as of July 03, 2025 at a share price of $13.76.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Arcutis’ ZORYVE® (roflumilast) Cream 0.15% Receives Strong Recommendation in American Academy of Dermatology Updated Guidelines for Adult Atopic Dermatitis
GlobeNewswire Inc.
Jun 26, 2025 12:00 PM GMT
The American Academy of Dermatology (AAD) provided evidence-based recommendation for the use of ZORYVE® (roflumilast) cream 0.15% in adults with mild to moderate atopic dermatitis (AD)Recommendation reflects ZORYVE’s proven efficacy, safety, and tole
Arcutis Enrolls First Child in INTEGUMENT-INFANT Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis
GlobeNewswire Inc.
Jun 10, 2025 12:00 PM GMT
Four-week Phase 2 study to evaluate investigational, once-daily ZORYVE .05% in infants as young as 3 months to less than 2 years with atopic dermatitisAtopic dermatitis impacts 9.6 million children in the United States; up to 60% of children with ato
Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference
GlobeNewswire Inc.
Jun 06, 2025 12:00 PM GMT
New data from the Phase 3 INTEGUMENT-OLE long-term open label study show durable improvement in the signs and symptoms of atopic dermatitis (AD), including almost half of participants achieving no or minimal itch with ZORYVE cream 0.15% or ZORYVE cre